RACHEL SMITH: Open Payments
NPI 1851323919 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,764 in 134 payments from 18 companies in 2025. Trend: 2023 $1,596 · 2024 $1,919 · 2025 $2,764
Food & beverage: $2,507Education: $258
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 17 | $441 |
| ABBVIE INC. | 31 | $411 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $317 |
| Regeneron Healthcare Solutions, Inc. | 8 | $259 |
| Novartis Pharmaceuticals Corporation | 10 | $193 |
| Galderma Laboratories, L.P. | 12 | $171 |
| Medtronic, Inc. | 5 | $169 |
| Janssen Biotech, Inc. | 11 | $158 |
| Lilly USA, LLC | 7 | $116 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
Products named: DUPIXENT, RINVOQ, ILUMYA, SKYRIZI, N/A, NEMLUVIO, TREMFYA, COSENTYX.
Industry payments across TX — which companies pay providers there.
